<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Almost 25% of patients with T-cell <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>) have <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific rearrangements of the TAL1 gene </plain></SENT>
<SENT sid="1" pm="."><plain>Although TAL1 expression has not been observed in <z:mpath ids='MPATH_458'>normal</z:mpath> lymphocytes, TAL1 gene products are readily detected in leukemic cells that harbor a rearranged TAL1 allele </plain></SENT>
<SENT sid="2" pm="."><plain>Hence, it has been proposed that ectopic expression of TAL1 promotes the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In this report, we show that TAL1 is expressed in the leukemic cells of most patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e>, including many that do not display an apparent TAL1 gene alteration </plain></SENT>
<SENT sid="4" pm="."><plain>A polymorphic <z:chebi fb="0" ids="47885">dinucleotide</z:chebi> repeat in the transcribed sequences of TAL1 was used to determine the allele specificity of TAL1 transcription in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">T-ALL</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>Monoallelic expression of TAL1 was observed in the leukemic cells of <z:hpo ids='HP_0000001'>all</z:hpo> patients (8 of 8) bearing a TAL1 gene rearrangement </plain></SENT>
<SENT sid="6" pm="."><plain>In the leukemic cells of patients without detectable TAL1 rearrangements, TAL1 transcription occurred in either a monoallelic (3 of 7 patients) or a biallelic (4 of 7 patients) fashion </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, TAL1 activation in these patients may result from subtle alterations in cis-acting regulatory sequences (affecting expression of a single TAL1 allele) or changes in trans-acting factors that control TAL1 transcription (affecting expression of both TAL1 alleles) </plain></SENT>
</text></document>